I-Tylvalosin Tartrate

Inkcazelo emfutshane:

CASinani: 63428-13-7

Ifomula yemolekyuli:C₅₃H₈₇NO₁₉

I-advanteji:Akukho xesha lokurhoxisa (iintsuku ezi-0);Umda wokhuseleko olubanzi

Umxholo:≥ 98%

Ukupakisha:25kg/igubu lekhadibhodi

Amalungiselelo:

Tylvalosin premix

Tylvalosin isisombululo

Tylvalosin tartrate premix 20%, 50%

FOB ixabiso	US $ 0.5 - 9,999 / Iqhekeza
Min.Order Ubungakanani	1 Iqhekeza / Amaqhekeza
Supply Ability	10000 Iqhekeza/Amaqhekeza ngenyanga
Ixesha lokuhlawula	T/T, D/P, D/A, L/C

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iprofayile yekhampani

Iithegi zeMveliso

I-Pharmacology kunye neToxicology

Tylvalosininomsebenzi we-antibacterial ngokuchasene neentlobo ze-bacteria ze-Gram-positive, ezifana ne-Staphylococcus, i-Micrococcus, i-Microbacteria, i-Bacillus, i-Corynebacterium, i-Balloon bacteria, i-Campylobacter, i-Enterococcus, i-Streptococcus, i-Arthrobacter, njl.;I-Mycoplasma nayo inomsebenzi omhle wokulwa ne-antibacterial kwaye isebenza ngcono kwiindawo eziphezulu;kodwa ayinasiphumo kwiibhaktheriya ezininzi ze-Gram-negative.

Isenzo se-Pharmacological

I-1.I-antibiotics yezilwanyana ezisebenzayo kwi-Mycoplasma suis kunye ne-ileitis zigcina umsebenzi oqhelekileyo we-immune system ye-respiratory mucosa ukukhusela ukuphunyuka kwe-pathogen.Unyango nge-Mycoplasma suis ngokukhawuleza lungena kwiiseli ze-epithelial zamathumbu kwaye lusebenze kwi-ribosomes ye-intracellular Lawsonia ukubulala ibhaktheriya.

2.Ukuphucula i-immunity jikelele ngokukhuthaza i-macrophage metabolism kunye nokwandisa inani le-macrophages kunye ne-lysosomal proteins kwi-macrophages.

3.Thintela ukuphindaphindwa kwe-PRRS.

Isalathiso

Iihagu: Unyango kunye nemethaphylaxis yehagu enzootic pneumonia;Unyango lwe-porcine proliferative enteropathy (ileitis);Unyango kunye ne-methaphylaxis ye-hagu dysentery.

Iinkukhu: Unyango kunye ne-methaphylaxis yesifo sokuphefumla esihambelana ne-Mycoplasma gallisepticum kwiinkukhu.,

IiTurkeys: Unyango lwezifo zokuphefumla ezinxulumene netylvalosin ebuthathaka kwiintlobo ze-Ornithobacterium rhinotracheale kwii-turkeys.

Ukusetyenziswa kweklinikhi kunye neempendulo ezimbi

Amalungiselelo eTylvalosin (njengama-premixes, i-powders e-soluble kunye ne-granules) ingasetyenziselwa iklinikhi ukukhusela nokuphatha i-asthma yehagu ebangelwa yi-Mycoplasma suis, i-haguine dysentery ebangelwa yi-B. hyodysenteriae, kunye ne-Lawsonia intracellularis Porcine proliferative enteritis kunye ne-Mycoplasma gallisepticum infection ebangelwa yi-Mycoplasma gallisepticum.Izilingo ezininzi zentsimi ziye zaqinisekisa ukuba iTyvanectin inempembelelo ebalulekileyo kunyango lwe-asthma yehagu, i-haguine dysentery kunye ne-porcine proliferative enteritis, ngokukhuseleka okuphezulu kwaye akukho ziphumo ezibi.Abaphandi balawula iihagu zovavanyo ngamaxesha angama-5, amaxesha angama-10 okanye amaxesha angama-20 kunomthamo ocetyiswayo.Uphononongo lufumene ukuba i-tyvans ayinayo impembelelo kubunzima bomzimba wehagu, ukutya okudliwayo, i-hematology, i-biochemistry yegazi, i-histopathology, njl., eyaneleyo.Ibonisa ukuba i-tyvans ayinayo impendulo engalunganga xa isetyenziswe kwiihagu, kwaye inokhuseleko oluphezulu.

Inzuzo

Akukho xesha lokurhoxisa (iintsuku ezi-0);

Umda wokhuseleko olubanzi

Amalungiselelo

Tylvalosin premix;isisombululo seTylvalosin;Tylvalosin tartrate premix 20%, 50%

Umxholo

≥ 98%

Ukupakisha

25kg/igubu lekhadibhodi

Ngaphambili: I-75% ye-Ethanol Solution ye-Disinfectant

Okulandelayo: I-Mixed Feed Additive ekusetyenzisweni kweenkukhu

I-Hebei Veyong Pharmaceutical Co., Ltd, yasekwa kwi-2002, ehlala kwisiXeko saseShijiazhuang, kwiPhondo laseHebei, eChina, ecaleni kwe-Capital Beijing.Ulishishini elikhulu leyeza lezilwanyana eliqinisekisiweyo le-GMP, eline-R&D, imveliso kunye nokuthengiswa kwee-APIs zonyango lwezilwanyana, amalungiselelo, ukutya okuxutywe kwangaphambili kunye nezongezo zokutya.NjengeZiko lobuGcisa lePhondo, iVeyong iye yaseka inkqubo yeR&D ehlaziyiweyo yeyeza elitsha lezilwanyana, kwaye lishishini elaziwa kuzwelonke leteknoloji esekelwe kunyango lwezilwanyana, kukho iingcali zobugcisa ezingama-65.I-Veyong ineziseko ezimbini zokuvelisa: i-Shijiazhuang kunye ne-Ordos, apho isiseko se-Shijiazhuang sihlanganisa indawo ye-78,706 m2, kunye neemveliso ze-API ze-13 ezibandakanya i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kunye ne-11, i-injection oral solutions, i-injection oral solutions. , i-premix, i-bolus, i-pesticides kunye ne-disinfectant, njl.IVeyong ibonelela ngee-APIs, ngaphezulu kwe-100 yamalungiselelo eleyibhile, kunye nenkonzo ye-OEM & ODM.

I-Veyong ibona ukubaluleka okukhulu kulawulo lwenkqubo ye-EHS(Environment, Health & Safety), kwaye ifumene i-ISO14001 kunye nezatifikethi ze-OHSAS18001.I-Veyong idweliswe kumashishini amashishini asakhasayo anobuchule kwiPhondo laseHebei kwaye inokuqinisekisa ukubonelela ngokuqhubekayo kweemveliso.

I-Veyong yaseka inkqubo epheleleyo yolawulo lomgangatho, yafumana isatifikethi se-ISO9001, isatifikethi se-GMP sase-China, isiqinisekiso se-APVMA se-GMP sase-Australia, isatifikethi se-GMP sase-Ethiopia, isatifikethi se-Ivermectin CEP, kwaye siphumelele ukuhlolwa kwe-US FDA.I-Veyong ineqela lobuchwephesha lobhaliso, intengiso kunye nenkonzo yobugcisa, inkampani yethu ifumene ukuthembela kunye nenkxaso kubathengi abaninzi ngomgangatho wemveliso ogqwesileyo, umgangatho ophezulu wokuthengisa kwangaphambili kunye nenkonzo yasemva kokuthengisa, ulawulo olunzulu kunye nolwenzululwazi.I-Veyong yenze intsebenziswano yexesha elide kunye namashishini amaninzi amachiza ezilwanyana awaziwayo ngamazwe ngamazwe kunye neemveliso ezithunyelwa eYurophu, eMzantsi Melika, kuMbindi Mpuma, e-Afrika, e-Asia, njl. ngaphezu kwamazwe angama-60 kunye nemimandla.